Alternative Splicing Events Are a Late Feature of Pathology in a Mouse Model of Spinal Muscular Atrophy
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Spinal muscular atrophy is a severe motor neuron disease caused by inactivating mutations in the SMN1 gene leading to reduced levels of full-length functional SMN protein. SMN is a critical mediator of spliceosomal protein assembly, and complete loss or drastic reduction in protein leads to loss of cell viability. However, the reason for selective motor neuron degeneration when SMN is reduced to levels which are tolerated by all other cell types is not currently understood. Widespread splicing abnormalities have recently been reported at end-stage in a mouse model of SMA, leading to the proposition that disruption of efficient splicing is the primary mechanism of motor neuron death. However, it remains unclear whether splicing abnormalities are present during early stages of the disease, which would be a requirement for a direct role in disease pathogenesis. We performed exon-array analysis of RNA from SMN deficient mouse spinal cord at 3 time points, pre-symptomatic (P1), early symptomatic (P7), and late-symptomatic (P13). Compared to littermate control mice, SMA mice showed a time-dependent increase in the number of exons showing differential expression, with minimal differences between genotypes at P1 and P7, but substantial variation in late-symptomatic (P13) mice. Gene ontology analysis revealed differences in pathways associated with neuronal development as well as cellular injury. Validation of selected targets by RT-PCR confirmed the array findings and was in keeping with a shift between physiologically occurring mRNA isoforms. We conclude that the majority of splicing changes occur late in SMA and may represent a secondary effect of cell injury, though we cannot rule out significant early changes in a small number of transcripts crucial to motor neuron survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consequently, splicing defects represent a prominent feature of SMA pathology, with aberrant pre-mRNA splicing observed in various in vitro and vivo models [10–16].”
From Widespread intron retention and exon skipping characterise alternative splicing changes in a C. elegans model of spinal muscular atrophy (2026) · cites this paper as [12]
In the citing paper
“Moreover, reductions in minor-class small nuclear RNAs (U12 snRNAs), accompanied by aberrant splicing of U12-type intron-containing transcripts, have been observed in both SMA patient-derived fibroblasts and SMA animal models.”
From Widespread intron retention and exon skipping characterise alternative splicing changes in a C. elegans model of spinal muscular atrophy (2026) · cites this paper as [12]
In the citing paper
“Moreover, our observation that widespread alternative splicing alterations occur in C. elegans smn-1(ok355) mutants at the stage of developmental arrest is consistent with findings in vertebrate models, where extensive splicing disruptions coincide with symptom onset and precede overt neurodegeneration in SMA [12].”
From Widespread intron retention and exon skipping characterise alternative splicing changes in a C. elegans model of spinal muscular atrophy (2026) · cites this paper as [12]
In the citing paper
“Moreover, our observation that widespread alternative splicing alterations occur in C. elegans smn-1(ok355) mutants at the stage of developmental arrest is consistent with findings in vertebrate models, where extensive splicing disruptions coincide with symptom onset and precede overt neurodegeneration in SMA [12].”
From Widespread intron retention and exon skipping characterise alternative splicing changes in a C. elegans model of spinal muscular atrophy (2026) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
limma: Linear Models for Microarray Data
Smyth, G. K. (2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0_23 · Cited by 5,796
Cited by
A day in the life of the spliceosome
Matera, A. G., & Wang, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3742 · Cited by 1,074
Kolb, S. J., & Kissel, J. T. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.004 · Cited by 603
Spinal muscular atrophy: going beyond the motor neuron
Hamilton, G., & Gillingwater, T. H. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.11.002 · Cited by 381
Self-citationAn SMN-Dependent U12 Splicing Event Essential for Motor Circuit Function
Lotti, F., Imlach, W. L., Saieva, L., Beck, E. S., Hao, L. T., Li, D. K., Jiao, W., Mentis, G. Z., Beattie, C. E., McCabe, B. D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.012 · Cited by 316
Diverse role of survival motor neuron protein
Singh, R. N., Howell, M. D., Ottesen, E. W., & Singh, N. N. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.12.008 · Cited by 300
Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions
Nussbacher, J. K., Tabet, R., Yeo, G. W., & Lagier-Tourenne, C. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.014 · Cited by 272
A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse
Porensky, P. N., Mitrpant, C., McGovern, V. L., Bevan, A. K., Foust, K. D., Kaspar, B. K., Wilton, S. D., & Burghes, A. H. M. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr600 · Cited by 248
“The reduced SnRNP assembly has been reported in SMA mice (29,30), and certainly specific target genes could have disrupted splicing (4,31).”
BackgroundLing, K. K. Y., Gibbs, R. M., Feng, Z., & Ko, C.-P. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr453 · Cited by 201
Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice
Heier, C. R., Satta, R., Lutz, C., & DiDonato, C. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq330 · Cited by 188
Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy
Wishart, T. M., Mutsaers, C. A., Riessland, M., Reimer, M. M., Hunter, G., Hannam, M. L., Eaton, S. L., Fuller, H. R., Roche, S. L., Somers, E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71318 · Cited by 176
Self-citationHubers, L., Valderrama-Carvajal, H., Laframboise, J., Timbers, J., Sanchez, G., & Côté, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq500 · Cited by 138
Developments in RNA Splicing and Disease
Poulos, M. G., Batra, R., Charizanis, K., & Swanson, M. S. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000778 · Cited by 98
“Indeed, a comparison of presymptomatic (postnatal day 1, P1), early-symptomatic (P7), and late-symptomatic (P13) mice showed that the majority of splicing changes in spinal cord were only observed in late-symptomatic mice (Baumer et al. 2009).”
BackgroundSMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy
Lauria, F., Bernabò, P., Tebaldi, T., Groen, E. J. N., Perenthaler, E., Maniscalco, F., Rossi, A., Donzel, D., Clamer, M., Marchioretto, M., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-00577-7 · Cited by 98
Self-citationRashid, S., Shen, A., Yong, A., Akay, A., & Dimitriadi, M. (2026) · Human Molecular Genetics · doi:10.1093/hmg/ddaf176 · Cited by 2
Metadata
- Authors
- Bäumer, D., Lee, S., Nicholson, G., Davies, J. L., Parkinson, N. J., Murray, L. M., Gillingwater, T. H., Ansorge, O., Davies, K. E., & Talbot, K.
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-12-18
- Volume
- 5
- Issue
- 12
- Pages
- e1000773
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- OpenAlex
- W2153484644
- Cited by
- 229
- References
- 2
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.